GlassScriptPhysician profile
Sean Michael Roark
NPI 1730384900
$3,199.94
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,039 · 2020: $433 · 2021: $637 · 2022: $636 · 2023: $394 · 2024: $61.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $461.42 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $451.57 | 2019-2024 | Ofev |
| Astrazeneca Pharmaceuticals LP | $421.14 | 2019-2023 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $325.65 | 2019-2022 | |
| Allergan, INC. | $133.45 | 2019-2020 | |
| United Therapeutics Corporation | $130.37 | 2020-2023 | Tyvaso |
| Genentech USA, INC. | $115.74 | 2019-2022 | |
| Amgen INC. | $112.82 | 2022-2023 | Tezspire |
| Electromed, INC. | $89.23 | 2022 | |
| Insmed, INC. | $83.18 | 2019-2020 | |
| Genzyme Corporation | $73.30 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $72.26 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $69.54 | 2019-2023 | Dupixent |
| Inspire Medical Systems, INC. | $69.25 | 2023-2024 | Inspire |
| Jazz Pharmaceuticals INC. | $60.82 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $58.47 | 2019-2023 | Yupelri |
| Merck Sharp & Dohme LLC | $55.20 | 2019-2023 | Recarbrio, Dificid, Zerbaxa |
| Gilead Sciences, INC. | $48.96 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.91 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $39.79 | 2023 | Acthar |
| Fisher & Paykel Healthcare INC | $35.04 | 2020 | |
| Alexion Pharmaceuticals, INC. | $34.25 | 2019-2022 | |
| Vapotherm INC | $27.47 | 2022 | |
| Nestle Healthcare Nutrition INC. | $21.02 | 2023 | |
| Baxter Healthcare | $19.55 | 2023 | Hillrom - Life 2000 Ventilation System |
| Chiesi USA, INC. | $16.64 | 2021 | |
| Philips North America LLC | $15.30 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $14.41 | 2021 | |
| Circassia INC. | $14.40 | 2019 | |
| Axsome Therapeutics, INC. | $14.10 | 2023 | Sunosi |
| Abbvie INC. | $13.80 | 2022 | |
| Cook Medical LLC | $13.29 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.60 | 2019 | |
| Grifols USA, LLC | $12.23 | 2021 | |
| La Jolla Pharmaceutical Company | $12.13 | 2022 | |
| Paratek Pharmaceuticals, INC. | $11.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Roark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.